Delivery Order SPE2DB20D1004-SPE2DB23FF8N0

Award Date 5/9/23
Potential Completion Date 5/10/23
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D1200|SPE2DB24FN3CX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564911228 TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,504.14, and is set to expire on June 17, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,469.14 Firm Fixed Price Delivery Order is for the supply of 4564690797 - TELMISARTAN 20 MG TABLET 30S to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TELMISARTAN 20 MG TABLET 30S. The single-award contract has a ceiling value of $1,006.22 and runs through December 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,299.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of June 18, 2024. The contract is for the provision of TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. This award is part of a larger...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FP4U9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,122.60, is for the delivery of 4558072627 TELMISARTAN 20 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 12, 2022. This contract award is not associated with a set-aside designation....
The federal contract award SPE2DB22D3301|SPE2DB25FX8VR was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4567012905 - TELMISARTAN 80 MG TABLET 30S. The contract has a firm fixed price of $1,157.00 and a completion date of January 23, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,674.67, is a delivery order for the supply of 4565040739 - TELMISARTAN 40 MG TABLET 30S. The contract has an ultimate completion date of July 2, 2024 and is a firm fixed price contract. Amerisourcebergen Drug Corp is the prime contractor and there is no indication of any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.30 Delivery Order contract is for the supply of 4560664400 TELMISARTAN 80 MG TABLET 30S. The contract has an ultimate completion date of April 21, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating...
This federal contract award, with an ID of SPE2DB20D3101|SPE2DB24FQVR7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $2,539.20 and a completion date of November 30, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRAL4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,369.91, is a Firm Fixed Price Delivery Order for the provision of 4567101009 - TELMISARTAN 80 MG TABLET 30S. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF8N0
    Delivery Order

This federal contract award, with the ID SPE2DB20D1004|SPE2DB23FF8N0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, which is not designated as a set-aside, is for the delivery of 4560879298 TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,315.51 and a completion date of May 10, 2023.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/9/25, 9:42 AM